[1]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111-114.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
　Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):111-114.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
点击复制

99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
40
期数:
2016年第2期
页码:
111-114
栏目:
出版日期:
2016-03-25

文章信息/Info

Title:
Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study
作者:
杨雷1;  袁卫红1;  王家平2;  高佳乐3;  杨青1;  赵莉莉2;  张怡1;  曾志1;  王丽娟1;  岳江红1
1. 650101 昆明, 昆明医科大学第二附属医院核医学科;
2. 650101 昆明, 昆明医科大学第二附属医院放射科;
3. 650500 昆明, 昆明医科大学公共卫生学院统计专业
Author(s):
Yang Lei1;  Yuan Weihong1;  Wang Jiaping2;  Gao Jiale3;  Yang Qing1;  Zhao Lili2;  Zhang Yi1;  Zeng Zhi1;  Wang Lijuan1;  Yue Jianghong1
1. Department of Nuclear Medicine, the Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China;
2. Department of Radiology, the Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China;
3. Statistics Profession, School of Public Health, Kunming Medical University, Kunming 650500, China
关键词:
乳腺肿瘤; 99m锝甲氧基异丁基异腈; 乳房X线摄影术
Keywords:
Breast neoplasms; Technetium tc 99m sestamibi; Mammography
DOI:
10.3760/cma.j.issn.1673-4114.2016.02.005
摘要:
目的 比较99Tcm-MIBI SPECT/CT显像和钼靶X线对女性乳腺癌的诊断价值。方法 女性患者83例,先行99Tcm-MIBI胸部SPECT/CT早期显像和延迟显像,并以延迟显像阳性为判定标准,再行乳腺钼靶X线摄影,并与最终的病理结果进行对照。结果 延迟显像的阳性患者为52例(T/NT值>3.33),阳性与阴性病灶的早期、延迟显像分别比较,差异均有统计学意义,且以延时2 h结果更为显著,最终病理结果证实45例为恶性病灶。99Tcm-MIBI显像结果的灵敏度为93.33%、特异度为73.68%、阳性预测值为80.77%、阴性预测值为90.32%;而钼靶X线对于相同病灶的灵敏度、特异度分别为64.44%、73.68%,阳性、阴性预测值分别为74.36%、63.63%。99Tcm-MIBI显像对乳腺癌诊断价值优于钼靶X线(χ2=4.11,P<0.05),但两种方法的一致性较差(>Kappa=0.217,P<0.05)。>结论 99Tcm-MIBI显像较之钼靶X线的结果判定更为客观,而两种方法同时运用则能提高乳腺癌的检出率,显著提高影像学对于乳腺癌的早期诊断。
Abstract:
Objective To compare the diagnostic value of 99Tcm-MIBI SPECT/CT chest imaging combined with X-ray mammography and to investigate their complementarity. Methods This study included 83 female patients, including those suspected to have breast nodules and those diagnosed with breast cancer. All patients were examined initially via 99Tcm-MIBI chest SPECT/CT imaging and delayed imaging followed by X-ray mammography, and all data were compared with final pathological results. Results Among the 99Tcm-MIBI imaging results of the 83 female patients, 52 lesions were revealed by delay images(T/NT ratio >3.33). The final criterion for diagnosis was based on positive delay imaging. The T/NT ratio between benign and malignant breast lesions was statistically significant(P<0.05). the="" sensitivity,="" specificity,="" positive="" predictive="" value="" and="" negative="" of="" diagnosis="" via="">99Tcm-MIBI SPECT/CT chest imaging were 93.33%, 73.68%, 80.77%, and 90.32%, respectively. The sensitivity, specificity, positive predictive value and negative predictive value of X-ray were 64.44%, 73.68%, 74.36%, 63.63%, respectively. 99Tcm-MIBI imaging superior value to diagnosis　X-ray mammogragh for breast cancer(χ2=4.11,P<0.05), but="" two="" methods="" of="" consistency="" spreads(Kappa=0.217,P<0.05).>Conclusions The sensitivity and specificity of 99Tcm-MIBI were higher than those of X-ray mammography in diagnosis of early-stage breast cancer. 99Tcm-MIBI imaging offers advantages in detecting virus infection aslar-pacific nodules. It is speculated that detecting regular breast nodules and occult lesions can be improved if these two methods are combined because they are complementary techniques.

参考文献/References:

[1] 邵志敏, 沈镇宙, 徐兵河. 乳腺肿瘤学[M]. 上海:复旦大学出版社, 2013:13-15. Shao ZM, Shen ZZ, Xu BH. Breast Oncology[M]. Shanghai:Fudan University Press, 2013:13-15.
[2] Del VS, Salvatore M. 99mTc-MIBI in the evaluation of breast cancer biology[J]. Eur J Nucl Med Mol Imaging, 2004, 31 Suppl 1:S88-96. DOI:10.1007/s00259-004-1530-0.
[3] Usmani S, Niaz K, Maseeh-Uz-Zaman, et al. Role of 99mTc-MIBI scintimammography and X-ray mammography in the diagnosis of locoregional recurrence of breast cancer[J]. J Pak Med Assoc, 2007, 57(4):172-175.
[4] Usmani S, Niaz K, Maseeh-Uz-Zaman, et al. Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammography[J]. Nucl Med Commun, 2007, 28(11):842-846. DOI:10.1097/MNM.0b013e3282eff2ec.
[5] 夏晓天, 张永学. 影像学检查在乳腺癌的诊断及疗效评估中的应用价值[J]. 国际放射医学核医学杂志, 2010, 34(4):242-246, 249. DOI:10. 3760/cma. j. issn. 1673-4114. 2010. 04. 014 Xia XT, Zhang YX. The value of imaging examinations in diagnosis and curative effect evaluation of breast cancer[J]. Int J Radiat Med Nucl Med, 2010, 34(4):242-246, 249.
[6] Arcan P, Ibis E, Aras G, et al. Identification of sentinel lymph node in stage Ⅰ-Ⅱ breast cancer with lymphoscintigraphy and surgical gamma probe:comparison of Tc-99m MIBI and Tc-99m sulfur colloid[J]. Clin Nucl Med, 2005, 30(5):317-321. DOI:10.1097/01. rlu. 0000159528. 12028. 1f.
[7] Schroeder JK, Kuemmel S, Pietzner K, et al. Optimizing the clinical management of gynecological and breast cancer via online tumor conferences[J]. Anticancer Res, 2011, 31(8):2669-2673.
[8] Kinuya S, Bai J, Shiba K, et al. 99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells[J]. Ann Nucl Med, 2006, 20(1):29-34. DOI:10.1007/BF02985587.

相似文献/References:

[1]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
　Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[2]樊孝廉,舒毅,曾春平,等.99Tcm-MIBI门控心肌灌注显像在2型糖尿病无症状心肌缺血患者中的价值[J].国际放射医学核医学杂志,2016,40(3):171.[doi:10.3760/cma.j.issn.1673-4114.2016.03.002]
　Fan Xiaolian,Shu Yi,Zeng Chunping,et al.Significance of 99Tcm-MIBI gated myocardial perfusion imaging in patients with type 2 diabetes but without myocardial ischemia symptoms[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):171.[doi:10.3760/cma.j.issn.1673-4114.2016.03.002]
[3]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
　chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[4]成钊汀,朱小华.99Tcm-MIBI显像在甲状旁腺功能亢进症中的应用及进展[J].国际放射医学核医学杂志,2015,39(1):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
　Cheng Zhaoting,Zhu Xiaohua.Application and progress of 99Tcm-MIBI scintieraphy in parathyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
[5]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
　Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[6]黄娟,颜剑豪,梁联保,等.注射钆剂后弥散加权成像对乳腺肿瘤诊断的影响[J].国际放射医学核医学杂志,2015,39(4):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
　Huang Juan,Yan Jianhao,Liang Lianbao,et al.Evaluation of the diffusion-weighted imaging after contrast for the characterization of breast tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
[7]李雯,冯彦林.18F-FDG PET/CT评估三阴性乳腺癌新辅助化疗疗效的研究进展[J].国际放射医学核医学杂志,2014,38(3):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
　Li Wen,Feng Yanlin.Advances of assessment with 18F-FDG PET/CT in triple-negative breast cancer during neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
[8]殷丽娜,张旭霞,张俊香,等.Wnt/β-catenin信号通路——乳腺癌的潜在治疗靶点[J].国际放射医学核医学杂志,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
　Yin Lina,Zhang Xuxia,Zhang Junxiang,et al.The Wnt/β-catenin signaling pathway-a potential therapeutic target of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
[9]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
　Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[10]胡梦裳,章斌.PET/CT显像在乳腺癌疗效评价及预后中的作用[J].国际放射医学核医学杂志,2014,38(5):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
　Hu Meng-shang,Zhang Bin.The role of PET/CT imaging in the evaluation of the efficacy and prognosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
[11]陈伟君,孙达.99Tcm-MIBI显像在乳腺癌新辅助化疗中的应用价值[J].国际放射医学核医学杂志,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
　Chen Weijun,Sun Da.Clinical value of 99Tcm-MIBI imaging in neoadjuvant chemotherapy of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
[12]夏晓天,张永学.影像学检查在乳腺癌的诊断及疗效评估中的应用价值[J].国际放射医学核医学杂志,2010,34(4):242.[doi:10.3760/cma.j.issn.1673-4114.2010.04.014]
　XIA Xiao-tian,ZHANG Yong-xue.The value of imaging examinations in diagnosis and curative effect evaluation of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):242.[doi:10.3760/cma.j.issn.1673-4114.2010.04.014]

备注/Memo

备注/Memo:
收稿日期:2015-11-05。
基金项目:云南省教育厅科研基金项目(08Y0232)
通讯作者:杨雷,Email:88115263@qq.com
更新日期/Last Update: 1900-01-01